Alseres Pharmaceuticals (Alseres Pharmaceuticals) Capex-to-Operating-Income : 0.00 (As of Jun. 2014)

Alseres Pharmaceuticals Capex-to-Operating-Income Chart

Alseres Pharmaceuticals Annual Data
	Trend	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Capex-to-Operating-Income		Get a 7-Day Free Trial					-	-	-	-	-

Alseres Pharmaceuticals Quarterly Data
	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14
Capex-to-Operating-Income	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Alseres Pharmaceuticals's Capex-to-Operating-Income

For the Biotechnology subindustry, Alseres Pharmaceuticals's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alseres Pharmaceuticals's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alseres Pharmaceuticals's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Alseres Pharmaceuticals's Capex-to-Operating-Income falls into.

Alseres Pharmaceuticals Capex-to-Operating-Income Calculation

Alseres Pharmaceuticals's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2013 is calculated as

Alseres Pharmaceuticals's Capex-to-Operating-Income for the quarter that ended in Jun. 2014 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alseres Pharmaceuticals  (OTCPK:ALSE) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Alseres Pharmaceuticals Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Alseres Pharmaceuticals's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Alseres Pharmaceuticals (Alseres Pharmaceuticals) Business Description